Part B News | Inflation Reduction Act Caps Insulin Costs, Grants CMS Drug Negotiating Power | News & Insights

Health Care Week in Review August 12, 2022

Health Care Week in Review: Congress Considers the Inflation Reduction Act of 2022

This week, Congress is expected to pass the Inflation Reduction Act of 2022, which includes numerous health-related provisions such as prescription drug inflation rebates; out-of-pocket caps for Medicare Part D; and drug price negotiation.

Health Care Week in Review June 7, 2019

Alston & Bird Health Care Week in Review, June 7, 2019

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and analyses; and other health policy news.

Health Care Week in Review May 31, 2019

Alston & Bird Healthcare Week in Review, May 31, 2019

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health policy news.

Health Care Week in Review September 1, 2023

Health Care Week In Review: HHS Selects the First 10 Drugs for Medicare Drug Price Negotiation

This week, the Biden Administration announced the first 10 Medicare Part D drugs selected for price negotiation and House Budget Committee Chair Jodey Arrington (R-TX) announced a Budget Committee Health Care Task Force and a Request for Information.

Health Care Week in Review August 25, 2023

Health Care Week in Review: CMS Announces Details to Pay Drug Costs on Installment Plan

This week, CMS released guidance on how Part D beneficiaries can pay their out-of-pocket monthly costs over the course of a year and HHS announced that the Medicare Shared Savings Program saved Medicare $1.8 billion in 2022.